Nebius Powers Past Meta Cloud Jitters With Record Capacity Growth and Healthcare Push
Published on 07/03/2026 at 12:01 | Redaktion boerse-global.de
Nebius shares staged a sharp recovery this week, clawing back losses triggered by reports that Meta Platforms is weighing a commercial cloud launch. The stock jumped 4.87% on Friday to €197.98, bringing its year-to-date gain to 158.8% and trimming the distance from its June 22 record of €261.00 to just over 24%.
The rebound came after a bruising midweek session in which Nebius and rival CoreWeave each lost more than 6% on a Bloomberg report that Meta is assessing plans to directly market its AI infrastructure to developers. While still unconfirmed, the prospect of the social-media giant entering the Neocloud market sent a chill through a sector already hypersensitive to supply-demand dynamics.
Yet the company’s own numbers offered a counterweight. On Thursday, Nebius reported first-quarter 2026 results that showed operational momentum accelerating well ahead of internal targets. The adjusted EBITDA margin in its AI cloud business nearly doubled to 45% in the quarter, comfortably above the full-year forecast of around 40%. Management attributed that to cost discipline rather than pricing power, a distinction that matters as the cloud arms race intensifies.
Even more striking was the capacity build-out. Nebius now has more than 3.5 gigawatts of contracted power capacity secured, up from an earlier target of more than 3 GW by year-end. The company raised the bar again, aiming for over 4 GW by the end of 2026. That expansion comes as it races to scale its data-center footprint from 170 megawatts to between 800 MW and 1 GW, and from seven to 16 facilities, by year-end.
Should investors sell immediately? Or is it worth buying Nebius?
Healthcare Awards Signal Vertical Expansion
Amid the market noise, Nebius also announced the winners of its AI Discovery Awards on July 2, a program designed to spotlight startups using artificial intelligence in biopharma, genomics and digital health. The company introduced two new categories this year—medical devices and medical imaging—citing a clear trend: connected diagnostic tools increasingly demand compute-intensive AI workloads that reshape clinical practice.
A total of 647 applications were received from around the world, with winners in the main categories receiving $100,000 plus compute and inference credits. Nebius also launched a dedicated Scientific AI and Healthcare Platform tailored to the cloud needs of health and life-science organisations. Dr. Ilya Burkov, the company’s global head of healthcare, said the awards are meant to compress research timelines by connecting teams with computing power, investor networks and mentorship.
The healthcare push fits into Nebius’s broader strategy of positioning itself as a cross-industry infrastructure provider for heavy AI workloads—a bet that now commands a capital spending plan of $20–$25 billion for 2026.
The Bull Case: Execution Speaks Louder Than Speculation
For optimists, the story is straightforward: Nebius is overdelivering on capacity and margins at a time when the market is fixated on potential threats. Management noted that component inflation will have only a low-single-digit percentage impact on this year’s investment programme because most capacity was already secured at 2025 prices. More than 75% of total power capacity now comes from contracts the company negotiated directly, reducing reliance on intermediaries.
Analyst ratings have remained largely on the buy side following the quarterly update. The stock’s relative strength index of 46.1 signals neither overbought nor oversold territory, leaving room for further gains—or reversals.
Nebius at a turning point? This analysis reveals what investors need to know now.
The Bear Case: Capital Hunger and Competitive Risk
Skeptics counter that the pace of infrastructure expansion carries its own dangers. Nebius is compressing a multiyear build-out into a narrow window, requiring enormous upfront cash outlays before utilisation and operating leverage kick in. The company will need to raise substantial new equity and debt to fund its data centres and GPU purchases, a capital-intensive phase that leaves it exposed to any delay in customer onboarding.
The Meta cloud plan, if it moves from rumour to a concrete, aggressively priced offering, could erode pricing power across the entire Neocloud segment just when Nebius most needs its margins to justify further capital rounds. The company is effectively trying to double its capacity in months while fending off a potential rival with vastly deeper pockets.
Outlook
For now, the operational momentum is winning the argument. As long as Nebius continues to beat its power-capacity guidance and holds EBITDA margins near target levels, the fundamental story should cushion any Meta-driven volatility. The next test will be whether Meta’s cloud ambitions crystallise into a formal product. Until then, the annualised 30-day volatility of 106% is likely to persist, leaving investors to weigh confirmed execution against a still-unfolding competitive threat.
Ad
Nebius Stock: New Analysis - 3 July
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
